BusinessZealand doses the first patients with ZP1848 for short bowel syndrome, advancing the second of its proprietary specialty medicines into Phase II development in 2016By Nasdaq OMXFeb 15, 2016, 7:38 AM UTC
BusinessNewLink Genetics to Host Its Fourth Quarter and Year End 2015 Financial Results Conference Call on February 29, 2016By Nasdaq OMXFeb 12, 2016, 12:00 PM UTC
BusinessMatinas BioPharma Receives Notice of Allowance of U.S. Patent for Novel Lipid-Crystal Nano-Particle Cochleate Formulation TechnologyBy Nasdaq OMXFeb 10, 2016, 1:05 PM UTC
BusinessOhr Pharmaceutical Reports First Quarter 2016 Financial and Business ResultsBy Nasdaq OMXFeb 9, 2016, 9:01 PM UTC
BusinessOhr Pharmaceutical to Present at the LEERINK Partners 5th Annual Global Healthcare Conference in New YorkBy Nasdaq OMXFeb 9, 2016, 2:49 PM UTC
BusinessAlder BioPharmaceuticals Strengthens and Expands Leadership Team Supporting Advancement of ALD403 Toward Future CommercializationBy Nasdaq OMXFeb 9, 2016, 1:00 PM UTC
BusinessZIOPHARM Announces First Patient Enrolled in Phase 1 Study of Second Generation Non-Viral CD19-Specific CAR T-Cell Therapy for Advanced Lymphoid MalignanciesBy Nasdaq OMXFeb 9, 2016, 12:00 PM UTC
BusinessAchillion to Present at the Leerink Partners 5th Annual Global Healthcare ConferenceBy Nasdaq OMXFeb 8, 2016, 9:05 PM UTC
